Free Trial

Oncology Institute (TOI) Competitors

Oncology Institute logo
$4.75 +0.14 (+3.04%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$4.78 +0.04 (+0.74%)
As of 10/24/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TOI vs. AHCO, FTRE, PNTG, PSNL, CDNA, INNV, FLGT, CSTL, AIRS, and AUNA

Should you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include AdaptHealth (AHCO), Fortrea (FTRE), The Pennant Group (PNTG), Personalis (PSNL), CareDx (CDNA), InnovAge (INNV), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), AirSculpt Technologies (AIRS), and Auna (AUNA). These companies are all part of the "healthcare" industry.

Oncology Institute vs. Its Competitors

Oncology Institute (NASDAQ:TOI) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Oncology Institute presently has a consensus price target of $7.00, indicating a potential upside of 47.37%. AdaptHealth has a consensus price target of $13.40, indicating a potential upside of 43.01%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities research analysts plainly believe Oncology Institute is more favorable than AdaptHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
AdaptHealth
2 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.43

Oncology Institute has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.

AdaptHealth has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$393.41M1.13-$64.66M-$0.68-6.99
AdaptHealth$3.26B0.39$90.42M$0.5417.35

AdaptHealth has a net margin of 2.49% compared to Oncology Institute's net margin of -14.26%. AdaptHealth's return on equity of 5.01% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-14.26% -1,527.21% -34.25%
AdaptHealth 2.49%5.01%1.77%

In the previous week, Oncology Institute had 3 more articles in the media than AdaptHealth. MarketBeat recorded 8 mentions for Oncology Institute and 5 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.58 beat Oncology Institute's score of 0.57 indicating that AdaptHealth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oncology Institute
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdaptHealth
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 1.6% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

AdaptHealth beats Oncology Institute on 11 of the 17 factors compared between the two stocks.

Get Oncology Institute News Delivered to You Automatically

Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TOI vs. The Competition

MetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$431.06M$8.46B$6.23B$10.67B
Dividend YieldN/A2.12%5.71%4.82%
P/E Ratio-6.9979.4730.0930.16
Price / Sales1.1342.77592.86133.57
Price / CashN/A21.6037.0161.44
Price / Book95.007.8412.046.60
Net Income-$64.66M$250.93M$3.32B$276.82M
7 Day Performance24.35%3.31%1.88%2.58%
1 Month Performance34.94%1.90%7.68%3.76%
1 Year Performance1,379.75%18.01%56.01%33.84%

Oncology Institute Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TOI
Oncology Institute
2.6431 of 5 stars
$4.75
+3.0%
$7.00
+47.4%
+1,348.2%$431.06M$393.41M-6.99660News Coverage
Analyst Forecast
Options Volume
Gap Up
AHCO
AdaptHealth
3.5641 of 5 stars
$9.47
+3.6%
$13.40
+41.5%
-11.3%$1.24B$3.26B17.5410,500News Coverage
Analyst Forecast
FTRE
Fortrea
3.2766 of 5 stars
$10.42
+10.3%
$12.39
+18.9%
-34.9%$858.06M$2.70B-0.9215,500
PNTG
The Pennant Group
3.8753 of 5 stars
$24.00
+1.5%
$34.40
+43.3%
-24.2%$817.04M$695.24M30.777,000News Coverage
Analyst Forecast
Short Interest ↑
PSNL
Personalis
2.9536 of 5 stars
$10.12
+10.8%
$7.42
-26.7%
+106.0%$809.62M$84.61M-7.91400Analyst Forecast
High Trading Volume
CDNA
CareDx
4.4746 of 5 stars
$15.22
+5.6%
$25.50
+67.5%
-34.5%$767M$333.79M14.92740News Coverage
Analyst Forecast
Gap Up
INNV
InnovAge
0.7293 of 5 stars
$5.35
+0.2%
$5.00
-6.5%
-9.1%$723.63M$853.70M-23.262,440Gap Up
FLGT
Fulgent Genetics
3.7804 of 5 stars
$23.84
+5.1%
$25.33
+6.3%
+24.0%$694.21M$283.47M-14.361,313
CSTL
Castle Biosciences
3.4898 of 5 stars
$23.01
+3.9%
$36.57
+58.9%
-22.9%$642.24M$332.07M-65.74540News Coverage
AIRS
AirSculpt Technologies
0.2994 of 5 stars
$10.33
+13.3%
$3.75
-63.7%
+103.4%$569.43M$165.11M-41.32240Gap Up
AUNA
Auna
4.2054 of 5 stars
$6.30
-0.2%
$10.70
+69.8%
-12.7%$467.02M$1.17B7.1614,842

Related Companies and Tools


This page (NASDAQ:TOI) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners